| product_name | (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid |
| CAS_number | 352665-43-1 |
| formula | C19H20N2O2 |
| molar_mass | 308.38 |
| melting_point | Not specified |
| boiling_point | Not specified |
| density | Not specified |
| solubility | Not specified |
| appearance | Not specified |
| specific_rotation | Not specified |
| flash_point | Not specified |
| refractive_index | Not specified |
| pKa | Not specified |
| logP | Not specified |
What is the chemical composition of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid?
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid is a compound with a complex molecular structure that contains various elements such as
carbon, hydrogen, nitrogen, and oxygen. This compound belongs to the class of acrylic acids
and is known for its potential biological activities.
What are the potential
pharmaceutical applications of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid?
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid has shown promise in various pharmaceutical applications due to its structural features
and interactions with biological targets. Studies have demonstrated its potential use in
drug development for conditions such as cancer, inflammation, and neurological
disorders.
How does
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid interact with biological systems?
The interaction of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid with biological systems involves binding to specific receptors or enzymes, leading to
various downstream effects. These interactions can modulate cellular signaling pathways,
gene expression, and protein function, ultimately influencing physiological
processes.
What are the mechanisms of action of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid?
The mechanisms of action of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid involve its ability to interact with specific molecular targets in biological systems.
This compound can exhibit inhibitory or stimulatory effects on enzymes, receptors, or other
proteins, leading to alterations in cellular processes and physiological
functions.
How is the bioavailability of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid optimized for therapeutic use?
The bioavailability of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid can be optimized through various formulations and delivery methods. Strategies such as
encapsulation, prodrug modifications, and targeted delivery systems can enhance the
absorption, distribution, and stability of the compound in biological systems, improving its
therapeutic efficacy.
What are the potential side effects or adverse reactions
associated with
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid?
Like any pharmaceutical compound,
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid may have potential side effects or adverse reactions. Common adverse effects may
include gastrointestinal disturbances, allergic reactions, or changes in laboratory
parameters. It is important to monitor patients closely during treatment and adjust dosages
accordingly.
What preclinical or clinical studies have been conducted on
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid?
Several preclinical and clinical studies have been conducted to investigate the
pharmacological properties and potential therapeutic applications of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid. These studies have explored the compound's efficacy, safety profile, and mechanisms of
action in various disease models or patient populations, providing valuable insights for
future development.
What are the future prospects for the use of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid in medicine?
The future prospects for the use of
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic
acid in medicine are promising, given its potential as a novel therapeutic agent for various
diseases. Ongoing research and development efforts aim to further elucidate its biological
activities, optimize its pharmacokinetic properties, and advance its clinical applications,
highlighting the compound's role in future healthcare innovations.
